Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xeris Pharmaceuticals (GB:0A8E)
LSE:0A8E
Holding GB:0A8E?
Track your performance easily
| Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 48.06M | $ 40.64M | $ 48.32M | - | $ 33.20M |
| Gross Profit | $ 40.27M | $ 34.67M | $ 40.12M | - | $ 33.20M |
| EBIT | $ -14.26M | $ -8.95M | $ -5.68M | - | $ -10.62M |
| EBITDA | $ -10.12M | $ -5.32M | $ -2.32M | - | $ -7.27M |
| Net Income Common Stockholders | $ -7.04M | $ -18.98M | $ -12.19M | - | $ -16.83M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 77.57M | $ 87.35M | $ 65.97M | $ 80.67M | $ 95.10M |
| Total Assets | $ 331.73M | $ 336.62M | $ 327.78M | $ 328.78M | $ 321.36M |
| Total Debt | $ 269.80M | $ 268.69M | $ 227.94M | $ 224.99M | $ 198.42M |
| Net Debt | $ 192.24M | $ 181.34M | $ 161.97M | $ 144.32M | $ 103.31M |
| Total Liabilities | $ 351.02M | $ 345.79M | $ 323.92M | $ 315.14M | $ 291.31M |
| Stockholders Equity | $ -19.28M | $ -9.18M | $ 3.87M | $ 13.69M | $ 30.05M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -10.74M | $ -20.47M | - | - | $ -26.38M |
| Operating Cash Flow | $ -10.35M | $ -20.30M | - | - | $ -26.14M |
| Investing Cash Flow | $ 4.60M | $ -19.65M | - | - | $ -43.98M |
| Financing Cash Flow | $ 659.00K | $ 35.19M | - | - | $ -863.00K |